AM-Pharma Revenue and Competitors

Bunnik,

Location

$241.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AM-Pharma's estimated annual revenue is currently $2.9M per year.(i)
  • AM-Pharma's estimated revenue per employee is $77,500
  • AM-Pharma's total funding is $241.6M.

Employee Data

  • AM-Pharma has 38 Employees.(i)
  • AM-Pharma grew their employee count by -33% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use.

keywords:N/A

$241.6M

Total Funding

38

Number of Employees

$2.9M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AM-Pharma's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
Executive AssistantReveal Email/Phone
5
VP Global Commercial StrategyReveal Email/Phone
6
Senior Scientific DirectorReveal Email/Phone
7
Director Quality Control & Analytical DevelopmentReveal Email/Phone
8
Director, Clinical Trial Site LiaisonReveal Email/Phone
9
Director PharmacovigilanceReveal Email/Phone
10
Director Pre-ClinicalReveal Email/Phone

AM-Pharma News

2022-04-17 - Acute Kidney Injury Treatment Market Size And Forecast ...

Quark Pharmaceuticals Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., AM-Pharma B.V.,...

2022-04-13 - Acute Kidney Injury Pipeline to Progress with Novel and Emerging Drugs for Treatment, Analyzes DelveInsight

The major Acute Kidney Injury companies include Atox Bio, AM Pharma Holding, Quark-Pharmaceuticals, LG Chem, Pharming Group, Angion Biomedica,...

2022-03-22 - AM-Pharma to Participate in SVB Leerink Biopharma Private ...

UTRECHT, The Netherlands--(BUSINESS WIRE)--AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical...

2020-04-03 - Daily funding roundup - April 2nd, 2020

Jenny Life raised $3.5M; SteadyMD closed $6M; Zucara Therapeutics landed $21M Atmosphere Atmosphere is a streaming TV service for businesses. Atmosphere has raised $5 million in fresh Series A funding that brings the total round to $14 million. Backers included Valor Siren Ventures and earlier ...

2020-01-24 - Dutch startups raised €1.5B in 2019: What about the future unicorns of the Netherlands

The Netherlands is one of the largest startup ecosystems in Europe, thanks to the ample innovation and unprecedented digital infrastructure in the country. It is expected that the Netherlands would deliver a couple of billion-dollar worth companies in the coming years. This seems to be possible ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8M61-10%N/A
#2
$12.5M63-30%N/A
#3
$14.6M645%N/A
#4
$9M698%N/A
#5
$9.4M72-6%N/A